Physician
Kern Rural Wellness Centers, INC.
Kern Rural Wellness Centers, INC. was paid $15.22M by Medicaid between Jan 2018 and May 2024, across 100 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 56% of everything it billed.
33Billing provider infoKERN RURAL WELLNESS CENTERS, INC.
ARVIN, CA 93203
ARVIN, CA 93203
33aNPI1902196256assigned 04/07/2011
33bProvider typeInternal Medicine Physician
28Total paid$15.22M
24GClaims369,135
24DCodes billed100
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#7 of 2,679
Median peer was paid$13K
This provider vs. median1,208×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,509 | $2.64M | |
| 2019 | 62,036 | $2.25M | |
| 2020 | 44,740 | $1.88M | |
| 2021 | 47,453 | $2.45M | |
| 2022 | 38,317 | $1.83M | |
| 2023 | 67,387 | $2.44M | |
| 2024incomplete | 37,693 | $1.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 56% | 140,343 | 84,011 | $8.48M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 120,697 | 75,643 | $4.87M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.3% | 12,628 | 7,410 | $495K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.7% | 2,271 | 2,119 | $257K |
| 59425 | 1.0% | 2,089 | 1,301 | $158K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,221 | 1,140 | $133K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,224 | 2,132 | $132K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,500 | 1,462 | $107K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,125 | 6,263 | $105K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,687 | 1,650 | $79K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 6,533 | 4,865 | $41K |
| 92551 | <1% | 2,584 | 2,536 | $34K |
88 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,196 | $29K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,048 | $25K |
| G0467 | Community health center visit, returning patient | <1% | 1,203 | $24K |
| 90686 | <1% | 1,746 | $24K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,033 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,624 | $20K |
| 81025 | <1% | 5,324 | $15K | |
| 81003 | <1% | 8,866 | $15K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 330 | $13K |
| 93000 | <1% | 371 | $13K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 609 | $9K |
| 90670 | <1% | 658 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 619 | $6K |
| 90723 | <1% | 538 | $6K | |
| 86480 | <1% | 91 | $5K | |
| 90647 | <1% | 438 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 627 | $4K |
| 82948 | <1% | 1,807 | $4K | |
| 90633 | <1% | 345 | $4K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,222 | $4K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 54 | $4K |
| 90710 | <1% | 298 | $3K | |
| 84481 | <1% | 223 | $3K | |
| 83540 | <1% | 562 | $3K | |
| 69209 | <1% | 330 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 314 | $3K |
| 90649 | <1% | 234 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 196 | $2K |
| 90648 | <1% | 232 | $2K | |
| 90715 | <1% | 169 | $2K | |
| 83735 | <1% | 396 | $2K | |
| 83550 | <1% | 344 | $2K | |
| 80061 | Lipid panel | <1% | 192 | $2K |
| 86696 | <1% | 60 | $2K | |
| 82570 | <1% | 446 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 12 | $2K |
| 99385 | <1% | 15 | $2K | |
| 84439 | <1% | 221 | $2K | |
| 83655 | <1% | 164 | $2K | |
| 90680 | <1% | 157 | $2K | |
| 99173 | <1% | 403 | $2K | |
| 99383 | <1% | 23 | $2K | |
| 82962 | <1% | 740 | $2K | |
| 90651 | <1% | 142 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 48 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 218 | $1K |
| 86695 | <1% | 60 | $1K | |
| 90716 | <1% | 120 | $1K | |
| 90707 | <1% | 109 | $1K | |
| 90700 | <1% | 107 | $1K | |
| 83525 | <1% | 108 | $1K | |
| 86580 | <1% | 461 | $1K | |
| 82043 | <1% | 197 | $1K | |
| 86901 | <1% | 308 | $747.84 | |
| 84550 | <1% | 181 | $725.81 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 95 | $610.30 |
| 86431 | <1% | 112 | $562.24 | |
| 90734 | <1% | 48 | $531.90 | |
| 90630 | <1% | 121 | $507.25 | |
| 86900 | <1% | 211 | $499.80 | |
| 90732 | <1% | 43 | $479.70 | |
| 90713 | <1% | 37 | $413.55 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | $374.04 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $372.84 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 12 | $366.48 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 54 | $337.92 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $283.64 |
| P9011 | Blood, split unit | <1% | 110 | $261.80 |
| 86592 | <1% | 64 | $243.20 | |
| 90696 | <1% | 27 | $223.20 | |
| 82728 | <1% | 15 | $181.05 | |
| 90744 | <1% | 12 | $131.85 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,848 | $74.19 |
| 84436 | <1% | 12 | $72.36 | |
| 84479 | <1% | 12 | $68.16 | |
| 3075F | 0% | 1,065 | $0.00 | |
| 3080F | 0% | 487 | $0.00 | |
| 3049F | 0% | 27 | $0.00 | |
| 3074F | 0% | 5,634 | $0.00 | |
| 3079F | 0% | 2,228 | $0.00 | |
| 3008F | 0% | 8,146 | $0.00 | |
| 3048F | 0% | 117 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 102 | $0.00 |
| 3044F | 0% | 373 | $0.00 | |
| Z1034 | 0% | 64 | $0.00 | |
| 3078F | 0% | 4,776 | $0.00 | |
| 3077F | 0% | 786 | $0.00 | |
| 3050F | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRAR, HARJEET (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Infusion and Clinical Services, INC | Bakersfield, CA | $29.08M |
| Infusion and Clinical Services, INC. | Bakersfield, CA | $18.47M |
| Nephrology Medical Group of Bakersfield INC | Bakersfield, CA | $1.37M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.